I wonder if Chillee have decided that a withdrawal of the loan facility and the necessity for a capital raising will result in them getting a larger slice of the pie?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%